Selected research
Industry Growth & Trends
Global Trastuzumab Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Trastuzumab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Trastuzumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Trastuzumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Trastuzumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Trastuzumab Injection include Celltrion, Glenmark, Samsung Bioepsis, AstraZeneca, Amgen, Shanghai Henlius Biotech, Hisun Biopharmaceutical, Pfizer and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Trastuzumab Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Trastuzumab Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Trastuzumab Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Trastuzumab Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Trastuzumab Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Trastuzumab Injection Market by Company
Celltrion
Glenmark
Samsung Bioepsis
AstraZeneca
Amgen
Shanghai Henlius Biotech
Hisun Biopharmaceutical
Pfizer
Roche
Mylan
Remegen Co., Ltd.
Trastuzumab Injection Segment by Type
60 mg
440 mg
150 mg
Others
Trastuzumab Injection Segment by Application
Hospitals
Clinics
Others
Trastuzumab Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trastuzumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Trastuzumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trastuzumab Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Trastuzumab Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Trastuzumab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 60 mg
- 440 mg
- 150 mg
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Celltrion
- Glenmark
- Samsung Bioepsis
- AstraZeneca
- Amgen
- Shanghai Henlius Biotech
- Hisun Biopharmaceutical
- Pfizer
- Roche
- Mylan
- Remegen Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Trastuzumab Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Trastuzumab Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Trastuzumab Injection Market by Type
- 1.3.1 60 mg
- 1.3.2 440 mg
- 1.3.3 150 mg
- 1.3.4 Others
- 1.4 Global Trastuzumab Injection Market Size by Type
- 1.4.1 Global Trastuzumab Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Trastuzumab Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Trastuzumab Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Trastuzumab Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Trastuzumab Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Trastuzumab Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Trastuzumab Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Trastuzumab Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Trastuzumab Injection Industry Trends
- 2.2 Trastuzumab Injection Industry Drivers
- 2.3 Trastuzumab Injection Industry Opportunities and Challenges
- 2.4 Trastuzumab Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Trastuzumab Injection Revenue (2021-2026)
- 3.2 Global Top Players by Trastuzumab Injection Sales (2021-2026)
- 3.3 Global Top Players by Trastuzumab Injection Price (2021-2026)
- 3.4 Global Trastuzumab Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Trastuzumab Injection Major Company Production Sites & Headquarters
- 3.6 Global Trastuzumab Injection Company, Product Type & Application
- 3.7 Global Trastuzumab Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Trastuzumab Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Trastuzumab Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Trastuzumab Injection Tier 1, Tier 2, and Tier 3
4 Trastuzumab Injection Regional Status and Outlook
- 4.1 Global Trastuzumab Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Trastuzumab Injection Historic Market Size by Region
- 4.2.1 Global Trastuzumab Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Trastuzumab Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Trastuzumab Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Trastuzumab Injection Forecasted Market Size by Region
- 4.3.1 Global Trastuzumab Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Trastuzumab Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Trastuzumab Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Trastuzumab Injection by Application
- 5.1 Trastuzumab Injection Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Trastuzumab Injection Market Size by Application
- 5.2.1 Global Trastuzumab Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Trastuzumab Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Trastuzumab Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Trastuzumab Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Trastuzumab Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Trastuzumab Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Trastuzumab Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Trastuzumab Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Celltrion
- 6.1.1 Celltrion Company Information
- 6.1.2 Celltrion Business Overview
- 6.1.3 Celltrion Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Celltrion Trastuzumab Injection Product Portfolio
- 6.1.5 Celltrion Recent Developments
- 6.2 Glenmark
- 6.2.1 Glenmark Company Information
- 6.2.2 Glenmark Business Overview
- 6.2.3 Glenmark Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Glenmark Trastuzumab Injection Product Portfolio
- 6.2.5 Glenmark Recent Developments
- 6.3 Samsung Bioepsis
- 6.3.1 Samsung Bioepsis Company Information
- 6.3.2 Samsung Bioepsis Business Overview
- 6.3.3 Samsung Bioepsis Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Samsung Bioepsis Trastuzumab Injection Product Portfolio
- 6.3.5 Samsung Bioepsis Recent Developments
- 6.4 AstraZeneca
- 6.4.1 AstraZeneca Company Information
- 6.4.2 AstraZeneca Business Overview
- 6.4.3 AstraZeneca Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 AstraZeneca Trastuzumab Injection Product Portfolio
- 6.4.5 AstraZeneca Recent Developments
- 6.5 Amgen
- 6.5.1 Amgen Company Information
- 6.5.2 Amgen Business Overview
- 6.5.3 Amgen Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Amgen Trastuzumab Injection Product Portfolio
- 6.5.5 Amgen Recent Developments
- 6.6 Shanghai Henlius Biotech
- 6.6.1 Shanghai Henlius Biotech Company Information
- 6.6.2 Shanghai Henlius Biotech Business Overview
- 6.6.3 Shanghai Henlius Biotech Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shanghai Henlius Biotech Trastuzumab Injection Product Portfolio
- 6.6.5 Shanghai Henlius Biotech Recent Developments
- 6.7 Hisun Biopharmaceutical
- 6.7.1 Hisun Biopharmaceutical Company Information
- 6.7.2 Hisun Biopharmaceutical Business Overview
- 6.7.3 Hisun Biopharmaceutical Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Hisun Biopharmaceutical Trastuzumab Injection Product Portfolio
- 6.7.5 Hisun Biopharmaceutical Recent Developments
- 6.8 Pfizer
- 6.8.1 Pfizer Company Information
- 6.8.2 Pfizer Business Overview
- 6.8.3 Pfizer Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Pfizer Trastuzumab Injection Product Portfolio
- 6.8.5 Pfizer Recent Developments
- 6.9 Roche
- 6.9.1 Roche Company Information
- 6.9.2 Roche Business Overview
- 6.9.3 Roche Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Roche Trastuzumab Injection Product Portfolio
- 6.9.5 Roche Recent Developments
- 6.10 Mylan
- 6.10.1 Mylan Company Information
- 6.10.2 Mylan Business Overview
- 6.10.3 Mylan Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Mylan Trastuzumab Injection Product Portfolio
- 6.10.5 Mylan Recent Developments
- 6.11 Remegen Co., Ltd.
- 6.11.1 Remegen Co., Ltd. Company Information
- 6.11.2 Remegen Co., Ltd. Business Overview
- 6.11.3 Remegen Co., Ltd. Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Remegen Co., Ltd. Trastuzumab Injection Product Portfolio
- 6.11.5 Remegen Co., Ltd. Recent Developments
7 North America by Country
- 7.1 North America Trastuzumab Injection Sales by Country
- 7.1.1 North America Trastuzumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Trastuzumab Injection Sales by Country (2021-2026)
- 7.1.3 North America Trastuzumab Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Trastuzumab Injection Market Size by Country
- 7.2.1 North America Trastuzumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Trastuzumab Injection Market Size by Country (2021-2026)
- 7.2.3 North America Trastuzumab Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Trastuzumab Injection Sales by Country
- 8.1.1 Europe Trastuzumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Trastuzumab Injection Sales by Country (2021-2026)
- 8.1.3 Europe Trastuzumab Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Trastuzumab Injection Market Size by Country
- 8.2.1 Europe Trastuzumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Trastuzumab Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Trastuzumab Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Trastuzumab Injection Sales by Country
- 9.1.1 Asia-Pacific Trastuzumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Trastuzumab Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Trastuzumab Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Trastuzumab Injection Market Size by Country
- 9.2.1 Asia-Pacific Trastuzumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Trastuzumab Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Trastuzumab Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Trastuzumab Injection Sales by Country
- 10.1.1 South America Trastuzumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Trastuzumab Injection Sales by Country (2021-2026)
- 10.1.3 South America Trastuzumab Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Trastuzumab Injection Market Size by Country
- 10.2.1 South America Trastuzumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Trastuzumab Injection Market Size by Country (2021-2026)
- 10.2.3 South America Trastuzumab Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Trastuzumab Injection Sales by Country
- 11.1.1 Middle East and Africa Trastuzumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Trastuzumab Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Trastuzumab Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Trastuzumab Injection Market Size by Country
- 11.2.1 Middle East and Africa Trastuzumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Trastuzumab Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Trastuzumab Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Trastuzumab Injection Value Chain Analysis
- 12.1.1 Trastuzumab Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Trastuzumab Injection Production Mode & Process
- 12.2 Trastuzumab Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Trastuzumab Injection Distributors
- 12.2.3 Trastuzumab Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst